Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengwei Zang

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Science Bulletin|December 27, 2017
Organ-specific alterations in circadian genes by vertical sleeve gastrectomy in an obese diabetic mouse modelQiwei Shen, Yeping Yang, Wenjuan Liu, et al.
Journal of Hepatology|February 13, 2025
Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathwayZhengshuai Liu, Shuang Wei, Yang Jiang, et al.
Circulation|November 2, 2005
The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitusAdriana Zuccollo, Chaomei Shi, Roberto Mastroianni, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2019
Hepatic posttranscriptional network comprised of CCR4-NOT deadenylase and FGF21 maintains systemic metabolic homeostasisMasahiro Morita, Nadeem Siddiqui, Sakie Katsumura, et al.
Hepatology (Baltimore, Md.)|May 2, 2023
Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesisGuannan Li, Hanqing Chen, Feng Shen, et al.
Cell Metabolism|April 5, 2011
AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant miceYu Li, Shanqin Xu, Maria M Mihaylova, et al.
Hepatology (Baltimore, Md.)|March 2, 2016
Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in miceQi Gong, Zhimin Hu, Feifei Zhang, et al.
The Journal of Clinical Investigation|November 3, 2021
LRG1 is an adipokine that mediates obesity-induced hepatosteatosis and insulin resistanceSijia He, Jiyoon Ryu, Juanhong Liu, et al.
Hepatology (Baltimore, Md.)|February 20, 2018
DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver diseaseHanqing Chen, Feng Shen, Alex Sherban, et al.
The Journal of Clinical Investigation|July 15, 2022
Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failureJing Ma, Adrien Guillot, Zhihong Yang, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Science Bulletin|December 27, 2017
Organ-specific alterations in circadian genes by vertical sleeve gastrectomy in an obese diabetic mouse modelQiwei Shen, Yeping Yang, Wenjuan Liu, et al.
Journal of Hepatology|February 13, 2025
Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathwayZhengshuai Liu, Shuang Wei, Yang Jiang, et al.
Circulation|November 2, 2005
The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitusAdriana Zuccollo, Chaomei Shi, Roberto Mastroianni, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2019
Hepatic posttranscriptional network comprised of CCR4-NOT deadenylase and FGF21 maintains systemic metabolic homeostasisMasahiro Morita, Nadeem Siddiqui, Sakie Katsumura, et al.
Hepatology (Baltimore, Md.)|May 2, 2023
Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesisGuannan Li, Hanqing Chen, Feng Shen, et al.
Cell Metabolism|April 5, 2011
AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant miceYu Li, Shanqin Xu, Maria M Mihaylova, et al.
Hepatology (Baltimore, Md.)|March 2, 2016
Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in miceQi Gong, Zhimin Hu, Feifei Zhang, et al.
The Journal of Clinical Investigation|November 3, 2021
LRG1 is an adipokine that mediates obesity-induced hepatosteatosis and insulin resistanceSijia He, Jiyoon Ryu, Juanhong Liu, et al.
Hepatology (Baltimore, Md.)|February 20, 2018
DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver diseaseHanqing Chen, Feng Shen, Alex Sherban, et al.
The Journal of Clinical Investigation|July 15, 2022
Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failureJing Ma, Adrien Guillot, Zhihong Yang, et al.
Pageof 4